Structure Therapeutics creates life-changing medicines for patients using advanced computational and structure-based technology. Our platform combines the latest advancements in computational chemistry, visualization of molecular interactions, and data integration to design orally available, superior medicines that overcome current limitations inbiologic and peptide drugs. We are advancing our clinical-stage pipeline of differentiated, efficacious and safe treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic and pulmonary conditions. At Structure, our team’s deep experience with complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development enables our bold vision: to design and develop world-class medicines with tremendous patient impact and broad commercial opportunity.

Biotechnology

Health Care

Pharmaceutical

Structure Therapeutics

Raymond Stevens

Chelsea Olsen

Aline Barth

Crystal Cotter Anglen

Robert Gatmaitan

Michael Pelayo

Belen Carrillo-Rivas, D.Phil.

Eric Meltzer

Yingli Ma

Xinglong Jiang

Xichen Lin

Tony Peng

Kanak Singh

Jun Y.

Blai Coll

The Scientific Team at Structure Therapeutics harnesses advanced computational chemistry and structural biology to design and develop groundbreaking medicinal therapies. Comprising industry experts in biology, chemistry, and computational sciences, the team focuses on creating orally available treatments for chronic diseases such as cardiovascular, metabolic, and pulmonary conditions. Their efforts drive the company’s mission to transform patient care by overcoming the limitations of current biologic and peptide drugs.

Scientific Team

Leadership Team

Finance and Accounting

Scientific Team

About

Team members

Other teams at Structure Therapeutics

Leadership Team

Finance and Accounting